387 related articles for article (PubMed ID: 16081651)
1. Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.
Wang L; Amphlett G; Blättler WA; Lambert JM; Zhang W
Protein Sci; 2005 Sep; 14(9):2436-46. PubMed ID: 16081651
[TBL] [Abstract][Full Text] [Related]
2. Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate.
Luo Q; Chung HH; Borths C; Janson M; Wen J; Joubert MK; Wypych J
Anal Chem; 2016 Jan; 88(1):695-702. PubMed ID: 26629796
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
Tassone P; Gozzini A; Goldmacher V; Shammas MA; Whiteman KR; Carrasco DR; Li C; Allam CK; Venuta S; Anderson KC; Munshi NC
Cancer Res; 2004 Jul; 64(13):4629-36. PubMed ID: 15231675
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry.
Wang L; Amphlett G; Lambert JM; Blättler W; Zhang W
Pharm Res; 2005 Aug; 22(8):1338-49. PubMed ID: 16078144
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes.
Wakankar AA; Feeney MB; Rivera J; Chen Y; Kim M; Sharma VK; Wang YJ
Bioconjug Chem; 2010 Sep; 21(9):1588-95. PubMed ID: 20698491
[TBL] [Abstract][Full Text] [Related]
6. Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
Erickson HK; Widdison WC; Mayo MF; Whiteman K; Audette C; Wilhelm SD; Singh R
Bioconjug Chem; 2010 Jan; 21(1):84-92. PubMed ID: 19891424
[TBL] [Abstract][Full Text] [Related]
7. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
[TBL] [Abstract][Full Text] [Related]
8. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
[TBL] [Abstract][Full Text] [Related]
9. In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.
Liu B; Guo H; Zhang J; Xue J; Yang Y; Qin T; Xu J; Guo Q; Zhang D; Qian W; Li B; Hou S; Dai J; Guo Y; Wang H
Mol Pharm; 2016 Aug; 13(8):2702-10. PubMed ID: 27377124
[TBL] [Abstract][Full Text] [Related]
10. Statistics of the distribution of the abundance of molecules with various drug loads in maytansinoid antibody-drug conjugates.
Goldmacher VS; Amphlett G; Wang L; Lazar AC
Mol Pharm; 2015 Jun; 12(6):1738-44. PubMed ID: 25635630
[TBL] [Abstract][Full Text] [Related]
11. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
[TBL] [Abstract][Full Text] [Related]
12. A reversed-phase high-performance liquid chromatography method for analysis of monoclonal antibody-maytansinoid immunoconjugates.
Fleming MS; Zhang W; Lambert JM; Amphlett G
Anal Biochem; 2005 May; 340(2):272-8. PubMed ID: 15840500
[TBL] [Abstract][Full Text] [Related]
13. Design of antibody-maytansinoid conjugates allows for efficient detoxification via liver metabolism.
Sun X; Widdison W; Mayo M; Wilhelm S; Leece B; Chari R; Singh R; Erickson H
Bioconjug Chem; 2011 Apr; 22(4):728-35. PubMed ID: 21391620
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry.
Lazar AC; Wang L; Blättler WA; Amphlett G; Lambert JM; Zhang W
Rapid Commun Mass Spectrom; 2005; 19(13):1806-14. PubMed ID: 15945030
[TBL] [Abstract][Full Text] [Related]
15. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
[TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1).
Liu Y; Zhou F; Sang H; Ye H; Chen Q; Yao L; Ni P; Wang G; Zhang J
J Pharm Biomed Anal; 2017 Apr; 137():170-177. PubMed ID: 28131055
[TBL] [Abstract][Full Text] [Related]
18. Statistical modeling of the drug load distribution on trastuzumab emtansine (Kadcyla), a lysine-linked antibody drug conjugate.
Kim MT; Chen Y; Marhoul J; Jacobson F
Bioconjug Chem; 2014 Jul; 25(7):1223-32. PubMed ID: 24873191
[TBL] [Abstract][Full Text] [Related]
19. Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla).
Chen Y; Kim MT; Zheng L; Deperalta G; Jacobson F
Bioconjug Chem; 2016 Sep; 27(9):2037-47. PubMed ID: 27458087
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
